GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

MSD's Gardasil®9, a nine-valent HPV vaccine, is approved for use in males between 16 and 26 years old by China's National Medical Products Administration on Monday. [Photo provided to chinadaily ...

United States-based global pharmaceutical company MSD said on Monday that China's National Medical Products Administration has approved the use of multiple new indications of Gardasil®9, its ...

MRK’s leading HPV vaccine, GARDASIL 9, faced challenges internationally due to inventory buildup within its Chinese distributor, which is expected to reduce shipments for the remainder of 2024.

SEATTLE — Since its approval by the U.S. Food and Drug Administration in 2006, the HPV vaccine has made considerable ... already suggest adolescents aged 9 to 14 get two doses.

MRK’s leading HPV vaccine, GARDASIL 9, faced challenges internationally due to inventory buildup within its Chinese distributor, which is expected to reduce shipments for the remainder of 2024.

products Gardasil and Gardasil 9. It's also a leader in the animal health business. However, its shares underperformed the market last year because Keytruda, its biggest moneymaker, could face ...

This drive aims to vaccinate girls aged 9 to 14 years specifically focused ... head and neck and may also cause genital warts. The HPV vaccine guards against the most dangerous strains- especially ...

Gardasil/Gardasil 9 shot up 59% to $1.5 billion on a bounce back in demand as COVID-19 restrictions eased and strong uptake in China.

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other ...